世界の未分化大細胞リンパ腫治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Anaplastic Large Cell Lymphoma Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3799 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、未分化大細胞リンパ腫治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（AKR-303、AZD-3463、ブレンツキシマブベドチン、CEP-28122、その他）、用途別市場規模（入院患者、外来患者）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・未分化大細胞リンパ腫治療薬の市場動向 ・企業の競争状況、市場シェア ・未分化大細胞リンパ腫治療薬の種類別市場規模と予測2016-2027（AKR-303、AZD-3463、ブレンツキシマブベドチン、CEP-28122、その他） ・未分化大細胞リンパ腫治療薬の用途別市場規模と予測2016-2027（入院患者、外来患者） ・未分化大細胞リンパ腫治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・未分化大細胞リンパ腫治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・未分化大細胞リンパ腫治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・未分化大細胞リンパ腫治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・未分化大細胞リンパ腫治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Akron Molecules AG、AstraZeneca Plc、Bayer AG、Celon Pharma Sp. z o.o.、Pfizer Inc.、Sareum Holdings Plc、Seattle Genetics, Inc.、Teva Pharmaceutical Industries Limited） ・結論

Market Analysis and Insights: Global Anaplastic Large Cell Lymphoma Therapeutics Market
The global Anaplastic Large Cell Lymphoma Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anaplastic Large Cell Lymphoma Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anaplastic Large Cell Lymphoma Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anaplastic Large Cell Lymphoma Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anaplastic Large Cell Lymphoma Therapeutics market.

Global Anaplastic Large Cell Lymphoma Therapeutics Scope and Market Size
Anaplastic Large Cell Lymphoma Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anaplastic Large Cell Lymphoma Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
AKR-303
AZD-3463
Brentuximab Vedotin
CEP-28122
Others

Segment by Application
In-Patient
Out-Patient

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Akron Molecules AG
AstraZeneca Plc
Bayer AG
Celon Pharma Sp. z o.o.
Pfizer Inc.
Sareum Holdings Plc
Seattle Genetics, Inc.
Teva Pharmaceutical Industries Limited

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anaplastic Large Cell Lymphoma Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 AKR-303
1.2.3 AZD-3463
1.2.4 Brentuximab Vedotin
1.2.5 CEP-28122
1.2.6 Others
1.3 Market by Application
1.3.1 Global Anaplastic Large Cell Lymphoma Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 In-Patient
1.3.3 Out-Patient
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Anaplastic Large Cell Lymphoma Therapeutics Market Perspective (2016-2027)
2.2 Anaplastic Large Cell Lymphoma Therapeutics Growth Trends by Regions
2.2.1 Anaplastic Large Cell Lymphoma Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anaplastic Large Cell Lymphoma Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Anaplastic Large Cell Lymphoma Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Anaplastic Large Cell Lymphoma Therapeutics Industry Dynamic
2.3.1 Anaplastic Large Cell Lymphoma Therapeutics Market Trends
2.3.2 Anaplastic Large Cell Lymphoma Therapeutics Market Drivers
2.3.3 Anaplastic Large Cell Lymphoma Therapeutics Market Challenges
2.3.4 Anaplastic Large Cell Lymphoma Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Anaplastic Large Cell Lymphoma Therapeutics Players by Revenue
3.1.1 Global Top Anaplastic Large Cell Lymphoma Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Anaplastic Large Cell Lymphoma Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Anaplastic Large Cell Lymphoma Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anaplastic Large Cell Lymphoma Therapeutics Revenue
3.4 Global Anaplastic Large Cell Lymphoma Therapeutics Market Concentration Ratio
3.4.1 Global Anaplastic Large Cell Lymphoma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anaplastic Large Cell Lymphoma Therapeutics Revenue in 2020
3.5 Anaplastic Large Cell Lymphoma Therapeutics Key Players Head office and Area Served
3.6 Key Players Anaplastic Large Cell Lymphoma Therapeutics Product Solution and Service
3.7 Date of Enter into Anaplastic Large Cell Lymphoma Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Anaplastic Large Cell Lymphoma Therapeutics Breakdown Data by Type
4.1 Global Anaplastic Large Cell Lymphoma Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Anaplastic Large Cell Lymphoma Therapeutics Forecasted Market Size by Type (2022-2027)

5 Anaplastic Large Cell Lymphoma Therapeutics Breakdown Data by Application
5.1 Global Anaplastic Large Cell Lymphoma Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Anaplastic Large Cell Lymphoma Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Anaplastic Large Cell Lymphoma Therapeutics Market Size (2016-2027)
6.2 North America Anaplastic Large Cell Lymphoma Therapeutics Market Size by Type
6.2.1 North America Anaplastic Large Cell Lymphoma Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Anaplastic Large Cell Lymphoma Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Anaplastic Large Cell Lymphoma Therapeutics Market Size by Type (2016-2027)
6.3 North America Anaplastic Large Cell Lymphoma Therapeutics Market Size by Application
6.3.1 North America Anaplastic Large Cell Lymphoma Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Anaplastic Large Cell Lymphoma Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Anaplastic Large Cell Lymphoma Therapeutics Market Size by Application (2016-2027)
6.4 North America Anaplastic Large Cell Lymphoma Therapeutics Market Size by Country
6.4.1 North America Anaplastic Large Cell Lymphoma Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Anaplastic Large Cell Lymphoma Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Anaplastic Large Cell Lymphoma Therapeutics Market Size (2016-2027)
7.2 Europe Anaplastic Large Cell Lymphoma Therapeutics Market Size by Type
7.2.1 Europe Anaplastic Large Cell Lymphoma Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Anaplastic Large Cell Lymphoma Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Anaplastic Large Cell Lymphoma Therapeutics Market Size by Type (2016-2027)
7.3 Europe Anaplastic Large Cell Lymphoma Therapeutics Market Size by Application
7.3.1 Europe Anaplastic Large Cell Lymphoma Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Anaplastic Large Cell Lymphoma Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Anaplastic Large Cell Lymphoma Therapeutics Market Size by Application (2016-2027)
7.4 Europe Anaplastic Large Cell Lymphoma Therapeutics Market Size by Country
7.4.1 Europe Anaplastic Large Cell Lymphoma Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Anaplastic Large Cell Lymphoma Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Anaplastic Large Cell Lymphoma Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Anaplastic Large Cell Lymphoma Therapeutics Market Size by Type
8.2.1 Asia-Pacific Anaplastic Large Cell Lymphoma Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anaplastic Large Cell Lymphoma Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anaplastic Large Cell Lymphoma Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Anaplastic Large Cell Lymphoma Therapeutics Market Size by Application
8.3.1 Asia-Pacific Anaplastic Large Cell Lymphoma Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anaplastic Large Cell Lymphoma Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anaplastic Large Cell Lymphoma Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Anaplastic Large Cell Lymphoma Therapeutics Market Size by Region
8.4.1 Asia-Pacific Anaplastic Large Cell Lymphoma Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anaplastic Large Cell Lymphoma Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Anaplastic Large Cell Lymphoma Therapeutics Market Size (2016-2027)
9.2 Latin America Anaplastic Large Cell Lymphoma Therapeutics Market Size by Type
9.2.1 Latin America Anaplastic Large Cell Lymphoma Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Anaplastic Large Cell Lymphoma Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Anaplastic Large Cell Lymphoma Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Anaplastic Large Cell Lymphoma Therapeutics Market Size by Application
9.3.1 Latin America Anaplastic Large Cell Lymphoma Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Anaplastic Large Cell Lymphoma Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Anaplastic Large Cell Lymphoma Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Anaplastic Large Cell Lymphoma Therapeutics Market Size by Country
9.4.1 Latin America Anaplastic Large Cell Lymphoma Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Anaplastic Large Cell Lymphoma Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Anaplastic Large Cell Lymphoma Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Anaplastic Large Cell Lymphoma Therapeutics Market Size by Type
10.2.1 Middle East & Africa Anaplastic Large Cell Lymphoma Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anaplastic Large Cell Lymphoma Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anaplastic Large Cell Lymphoma Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Anaplastic Large Cell Lymphoma Therapeutics Market Size by Application
10.3.1 Middle East & Africa Anaplastic Large Cell Lymphoma Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anaplastic Large Cell Lymphoma Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anaplastic Large Cell Lymphoma Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Anaplastic Large Cell Lymphoma Therapeutics Market Size by Country
10.4.1 Middle East & Africa Anaplastic Large Cell Lymphoma Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anaplastic Large Cell Lymphoma Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Akron Molecules AG
11.1.1 Akron Molecules AG Company Details
11.1.2 Akron Molecules AG Business Overview
11.1.3 Akron Molecules AG Anaplastic Large Cell Lymphoma Therapeutics Introduction
11.1.4 Akron Molecules AG Revenue in Anaplastic Large Cell Lymphoma Therapeutics Business (2016-2021)
11.1.5 Akron Molecules AG Recent Development
11.2 AstraZeneca Plc
11.2.1 AstraZeneca Plc Company Details
11.2.2 AstraZeneca Plc Business Overview
11.2.3 AstraZeneca Plc Anaplastic Large Cell Lymphoma Therapeutics Introduction
11.2.4 AstraZeneca Plc Revenue in Anaplastic Large Cell Lymphoma Therapeutics Business (2016-2021)
11.2.5 AstraZeneca Plc Recent Development
11.3 Bayer AG
11.3.1 Bayer AG Company Details
11.3.2 Bayer AG Business Overview
11.3.3 Bayer AG Anaplastic Large Cell Lymphoma Therapeutics Introduction
11.3.4 Bayer AG Revenue in Anaplastic Large Cell Lymphoma Therapeutics Business (2016-2021)
11.3.5 Bayer AG Recent Development
11.4 Celon Pharma Sp. z o.o.
11.4.1 Celon Pharma Sp. z o.o. Company Details
11.4.2 Celon Pharma Sp. z o.o. Business Overview
11.4.3 Celon Pharma Sp. z o.o. Anaplastic Large Cell Lymphoma Therapeutics Introduction
11.4.4 Celon Pharma Sp. z o.o. Revenue in Anaplastic Large Cell Lymphoma Therapeutics Business (2016-2021)
11.4.5 Celon Pharma Sp. z o.o. Recent Development
11.5 Pfizer Inc.
11.5.1 Pfizer Inc. Company Details
11.5.2 Pfizer Inc. Business Overview
11.5.3 Pfizer Inc. Anaplastic Large Cell Lymphoma Therapeutics Introduction
11.5.4 Pfizer Inc. Revenue in Anaplastic Large Cell Lymphoma Therapeutics Business (2016-2021)
11.5.5 Pfizer Inc. Recent Development
11.6 Sareum Holdings Plc
11.6.1 Sareum Holdings Plc Company Details
11.6.2 Sareum Holdings Plc Business Overview
11.6.3 Sareum Holdings Plc Anaplastic Large Cell Lymphoma Therapeutics Introduction
11.6.4 Sareum Holdings Plc Revenue in Anaplastic Large Cell Lymphoma Therapeutics Business (2016-2021)
11.6.5 Sareum Holdings Plc Recent Development
11.7 Seattle Genetics, Inc.
11.7.1 Seattle Genetics, Inc. Company Details
11.7.2 Seattle Genetics, Inc. Business Overview
11.7.3 Seattle Genetics, Inc. Anaplastic Large Cell Lymphoma Therapeutics Introduction
11.7.4 Seattle Genetics, Inc. Revenue in Anaplastic Large Cell Lymphoma Therapeutics Business (2016-2021)
11.7.5 Seattle Genetics, Inc. Recent Development
11.8 Teva Pharmaceutical Industries Limited
11.8.1 Teva Pharmaceutical Industries Limited Company Details
11.8.2 Teva Pharmaceutical Industries Limited Business Overview
11.8.3 Teva Pharmaceutical Industries Limited Anaplastic Large Cell Lymphoma Therapeutics Introduction
11.8.4 Teva Pharmaceutical Industries Limited Revenue in Anaplastic Large Cell Lymphoma Therapeutics Business (2016-2021)
11.8.5 Teva Pharmaceutical Industries Limited Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Anaplastic Large Cell Lymphoma Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of AKR-303
Table 3. Key Players of AZD-3463
Table 4. Key Players of Brentuximab Vedotin
Table 5. Key Players of CEP-28122
Table 6. Key Players of Others
Table 7. Global Anaplastic Large Cell Lymphoma Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Anaplastic Large Cell Lymphoma Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Anaplastic Large Cell Lymphoma Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Anaplastic Large Cell Lymphoma Therapeutics Market Share by Regions (2016-2021)
Table 11. Global Anaplastic Large Cell Lymphoma Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Anaplastic Large Cell Lymphoma Therapeutics Market Share by Regions (2022-2027)
Table 13. Anaplastic Large Cell Lymphoma Therapeutics Market Trends
Table 14. Anaplastic Large Cell Lymphoma Therapeutics Market Drivers
Table 15. Anaplastic Large Cell Lymphoma Therapeutics Market Challenges
Table 16. Anaplastic Large Cell Lymphoma Therapeutics Market Restraints
Table 17. Global Anaplastic Large Cell Lymphoma Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Anaplastic Large Cell Lymphoma Therapeutics Market Share by Players (2016-2021)
Table 19. Global Top Anaplastic Large Cell Lymphoma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anaplastic Large Cell Lymphoma Therapeutics as of 2020)
Table 20. Ranking of Global Top Anaplastic Large Cell Lymphoma Therapeutics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Anaplastic Large Cell Lymphoma Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Anaplastic Large Cell Lymphoma Therapeutics Product Solution and Service
Table 24. Date of Enter into Anaplastic Large Cell Lymphoma Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Anaplastic Large Cell Lymphoma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Anaplastic Large Cell Lymphoma Therapeutics Revenue Market Share by Type (2016-2021)
Table 28. Global Anaplastic Large Cell Lymphoma Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Anaplastic Large Cell Lymphoma Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Anaplastic Large Cell Lymphoma Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Anaplastic Large Cell Lymphoma Therapeutics Revenue Market Share by Application (2016-2021)
Table 32. Global Anaplastic Large Cell Lymphoma Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Anaplastic Large Cell Lymphoma Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Anaplastic Large Cell Lymphoma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Anaplastic Large Cell Lymphoma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Anaplastic Large Cell Lymphoma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Anaplastic Large Cell Lymphoma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Anaplastic Large Cell Lymphoma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Anaplastic Large Cell Lymphoma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Anaplastic Large Cell Lymphoma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Anaplastic Large Cell Lymphoma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Anaplastic Large Cell Lymphoma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Anaplastic Large Cell Lymphoma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Anaplastic Large Cell Lymphoma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Anaplastic Large Cell Lymphoma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Anaplastic Large Cell Lymphoma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Anaplastic Large Cell Lymphoma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Anaplastic Large Cell Lymphoma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Anaplastic Large Cell Lymphoma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Anaplastic Large Cell Lymphoma Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Anaplastic Large Cell Lymphoma Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Anaplastic Large Cell Lymphoma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Anaplastic Large Cell Lymphoma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Anaplastic Large Cell Lymphoma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Anaplastic Large Cell Lymphoma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Anaplastic Large Cell Lymphoma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Anaplastic Large Cell Lymphoma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Anaplastic Large Cell Lymphoma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Anaplastic Large Cell Lymphoma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Anaplastic Large Cell Lymphoma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Anaplastic Large Cell Lymphoma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Anaplastic Large Cell Lymphoma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Anaplastic Large Cell Lymphoma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 64. Akron Molecules AG Company Details
Table 65. Akron Molecules AG Business Overview
Table 66. Akron Molecules AG Anaplastic Large Cell Lymphoma Therapeutics Product
Table 67. Akron Molecules AG Revenue in Anaplastic Large Cell Lymphoma Therapeutics Business (2016-2021) & (US$ Million)
Table 68. Akron Molecules AG Recent Development
Table 69. AstraZeneca Plc Company Details
Table 70. AstraZeneca Plc Business Overview
Table 71. AstraZeneca Plc Anaplastic Large Cell Lymphoma Therapeutics Product
Table 72. AstraZeneca Plc Revenue in Anaplastic Large Cell Lymphoma Therapeutics Business (2016-2021) & (US$ Million)
Table 73. AstraZeneca Plc Recent Development
Table 74. Bayer AG Company Details
Table 75. Bayer AG Business Overview
Table 76. Bayer AG Anaplastic Large Cell Lymphoma Therapeutics Product
Table 77. Bayer AG Revenue in Anaplastic Large Cell Lymphoma Therapeutics Business (2016-2021) & (US$ Million)
Table 78. Bayer AG Recent Development
Table 79. Celon Pharma Sp. z o.o. Company Details
Table 80. Celon Pharma Sp. z o.o. Business Overview
Table 81. Celon Pharma Sp. z o.o. Anaplastic Large Cell Lymphoma Therapeutics Product
Table 82. Celon Pharma Sp. z o.o. Revenue in Anaplastic Large Cell Lymphoma Therapeutics Business (2016-2021) & (US$ Million)
Table 83. Celon Pharma Sp. z o.o. Recent Development
Table 84. Pfizer Inc. Company Details
Table 85. Pfizer Inc. Business Overview
Table 86. Pfizer Inc. Anaplastic Large Cell Lymphoma Therapeutics Product
Table 87. Pfizer Inc. Revenue in Anaplastic Large Cell Lymphoma Therapeutics Business (2016-2021) & (US$ Million)
Table 88. Pfizer Inc. Recent Development
Table 89. Sareum Holdings Plc Company Details
Table 90. Sareum Holdings Plc Business Overview
Table 91. Sareum Holdings Plc Anaplastic Large Cell Lymphoma Therapeutics Product
Table 92. Sareum Holdings Plc Revenue in Anaplastic Large Cell Lymphoma Therapeutics Business (2016-2021) & (US$ Million)
Table 93. Sareum Holdings Plc Recent Development
Table 94. Seattle Genetics, Inc. Company Details
Table 95. Seattle Genetics, Inc. Business Overview
Table 96. Seattle Genetics, Inc. Anaplastic Large Cell Lymphoma Therapeutics Product
Table 97. Seattle Genetics, Inc. Revenue in Anaplastic Large Cell Lymphoma Therapeutics Business (2016-2021) & (US$ Million)
Table 98. Seattle Genetics, Inc. Recent Development
Table 99. Teva Pharmaceutical Industries Limited Company Details
Table 100. Teva Pharmaceutical Industries Limited Business Overview
Table 101. Teva Pharmaceutical Industries Limited Revenue in Anaplastic Large Cell Lymphoma Therapeutics Business (2016-2021) & (US$ Million)
Table 102. Teva Pharmaceutical Industries Limited Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anaplastic Large Cell Lymphoma Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. AKR-303 Features
Figure 3. AZD-3463 Features
Figure 4. Brentuximab Vedotin Features
Figure 5. CEP-28122 Features
Figure 6. Others Features
Figure 7. Global Anaplastic Large Cell Lymphoma Therapeutics Market Share by Application: 2020 VS 2027
Figure 8. In-Patient Case Studies
Figure 9. Out-Patient Case Studies
Figure 10. Anaplastic Large Cell Lymphoma Therapeutics Report Years Considered
Figure 11. Global Anaplastic Large Cell Lymphoma Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Anaplastic Large Cell Lymphoma Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Anaplastic Large Cell Lymphoma Therapeutics Market Share by Regions: 2020 VS 2027
Figure 14. Global Anaplastic Large Cell Lymphoma Therapeutics Market Share by Regions (2022-2027)
Figure 15. Global Anaplastic Large Cell Lymphoma Therapeutics Market Share by Players in 2020
Figure 16. Global Top Anaplastic Large Cell Lymphoma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anaplastic Large Cell Lymphoma Therapeutics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Anaplastic Large Cell Lymphoma Therapeutics Revenue in 2020
Figure 18. Global Anaplastic Large Cell Lymphoma Therapeutics Revenue Market Share by Type (2016-2021)
Figure 19. Global Anaplastic Large Cell Lymphoma Therapeutics Revenue Market Share by Type (2022-2027)
Figure 20. North America Anaplastic Large Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Anaplastic Large Cell Lymphoma Therapeutics Market Share by Type (2016-2027)
Figure 22. North America Anaplastic Large Cell Lymphoma Therapeutics Market Share by Application (2016-2027)
Figure 23. North America Anaplastic Large Cell Lymphoma Therapeutics Market Share by Country (2016-2027)
Figure 24. United States Anaplastic Large Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Anaplastic Large Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Anaplastic Large Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Anaplastic Large Cell Lymphoma Therapeutics Market Share by Type (2016-2027)
Figure 28. Europe Anaplastic Large Cell Lymphoma Therapeutics Market Share by Application (2016-2027)
Figure 29. Europe Anaplastic Large Cell Lymphoma Therapeutics Market Share by Country (2016-2027)
Figure 30. Germany Anaplastic Large Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Anaplastic Large Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Anaplastic Large Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Anaplastic Large Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Anaplastic Large Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Anaplastic Large Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Anaplastic Large Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Anaplastic Large Cell Lymphoma Therapeutics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Anaplastic Large Cell Lymphoma Therapeutics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Anaplastic Large Cell Lymphoma Therapeutics Market Share by Region (2016-2027)
Figure 40. China Anaplastic Large Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Anaplastic Large Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Anaplastic Large Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Anaplastic Large Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Anaplastic Large Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Anaplastic Large Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Anaplastic Large Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Anaplastic Large Cell Lymphoma Therapeutics Market Share by Type (2016-2027)
Figure 48. Latin America Anaplastic Large Cell Lymphoma Therapeutics Market Share by Application (2016-2027)
Figure 49. Latin America Anaplastic Large Cell Lymphoma Therapeutics Market Share by Country (2016-2027)
Figure 50. Mexico Anaplastic Large Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Anaplastic Large Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Anaplastic Large Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Anaplastic Large Cell Lymphoma Therapeutics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Anaplastic Large Cell Lymphoma Therapeutics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Anaplastic Large Cell Lymphoma Therapeutics Market Share by Country (2016-2027)
Figure 56. Turkey Anaplastic Large Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Anaplastic Large Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Anaplastic Large Cell Lymphoma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Akron Molecules AG Revenue Growth Rate in Anaplastic Large Cell Lymphoma Therapeutics Business (2016-2021)
Figure 60. AstraZeneca Plc Revenue Growth Rate in Anaplastic Large Cell Lymphoma Therapeutics Business (2016-2021)
Figure 61. Bayer AG Revenue Growth Rate in Anaplastic Large Cell Lymphoma Therapeutics Business (2016-2021)
Figure 62. Celon Pharma Sp. z o.o. Revenue Growth Rate in Anaplastic Large Cell Lymphoma Therapeutics Business (2016-2021)
Figure 63. Pfizer Inc. Revenue Growth Rate in Anaplastic Large Cell Lymphoma Therapeutics Business (2016-2021)
Figure 64. Sareum Holdings Plc Revenue Growth Rate in Anaplastic Large Cell Lymphoma Therapeutics Business (2016-2021)
Figure 65. Seattle Genetics, Inc. Revenue Growth Rate in Anaplastic Large Cell Lymphoma Therapeutics Business (2016-2021)
Figure 66. Teva Pharmaceutical Industries Limited Revenue Growth Rate in Anaplastic Large Cell Lymphoma Therapeutics Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---